In a nutshell Key findings from the Yale School of Medicine research: Healthcare companies distributed $2.6 trillion to shareholders over the past two decades, with just 19 companies accounting for 80 ...
Attorneys general sued the Trump administration to block a NIH decision that would slash grant payments for research overhead ...
A study has identified a wheat nucleotide-binding and leucine-rich repeat (NLR) gene pair, RXL and Pm5e, that confers ...
Learn more about whether Halozyme Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...
Egypt’s pharmaceutical industry produces over 90% of its medicines domestically and exports to more than 100 countries.
That’s the conclusion of hiring managers at four of the state’s leading life sciences companies who spoke at a recent career ...
Learn more about whether Protagonist Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on ...
Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the ...
It's widely recognized that health care is a growing expense for many Americans. However, what health care companies do with ...
Trump’s NIH cuts could cost UTSW $100 million annually. Over the weekend, the president of UT Southwestern, Dr. Daniel K. Podolsky, sent an email to the university’s employees ...
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular behavior and gene function.
One of Cincinnati’s best-funded startups further cemented its place on that list last year.